AMWL (American Well) YoY EBITDA Growth: 80.26% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMWL American Well Corp AMWL
50 GF Score
Price $11.92
GF Value $6.41
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is American Well YoY EBITDA Growth?

American Well AMWL +0.17% 50 YoY EBITDA Growth is 80.26% as of Jun. 2026. GuruFocus rates AMWL with a GF Score™ of 50/100 and a GF Value™ of $6.41 (Significantly Overvalued). The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. American Well's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 80.26%.

American Well's EBITDA per Share for the three months ended in Jun. 2026 was $-0.15.

American Well YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for American Well's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Well YoY EBITDA Growth Chart

American Well Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial 70.75 -41.86 13.39 21.98 63.88

American Well Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.23 52.46 54.75 58.91 80.26
AMWL
50GF Score
American Well Corp AMWL
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

American Well YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

American Well's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-4.444--12.304)/ | -12.304 |
=63.88 %

American Well's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(-0.151--0.765)/ | -0.765 |
=80.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 80.26% mean?
American Well (AMWL) has a YoY EBITDA Growth of 80.26% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for American Well and its competitors.
Is American Well's YoY EBITDA Growth too high?
American Well's current YoY EBITDA Growth is 80.26%. Overall, American Well has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does American Well's YoY EBITDA Growth compare to LFMD and SY?
American Well's YoY EBITDA Growth of 80.26% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for American Well and its competitors. American Well's current YoY EBITDA Growth is 80.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Well stock overvalued right now?
Based on GuruFocus' analysis, American Well (AMWL) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.41, compared to a current price of $11.92 — trading 86% above its estimated fair value. The current YoY EBITDA Growth is 80.26%. American Well's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For American Well (AMWL), the current YoY EBITDA Growth is 80.26% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is American Well (AMWL) Overvalued in 2026?

Based on GuruFocus' analysis, American Well stock appears to be overvalued. The current stock price of $11.92 is trading 86% above its estimated GF Value™ of $6.41. GuruFocus considers American Well to be Significantly Overvalued.

Key valuation signals for AMWL:

  • YoY EBITDA Growth: 80.26%
  • GF Value™: $6.41 vs. price of $11.92 (86% above fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the AMWL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

American Well Business Description

Address 75 State Street, 26th Floor, Boston, MA, USA, 02109
American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.
50GF Score

Get the complete analysis for AMWL

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.92
Price
$6.41
GF Value